Chat about Faron Pharma accounts information. See how Faron Pharma is performing financially.

Faron Pharma Accounts Summary


Date of Accounts 20232022202120202019
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement31-12-202331-12-202231-12-202131-12-202031-12-2019
Revenuen/an/an/an/an/a
Operating Profit / Loss-28.57-27.43-21.11-16.65-13.10
Net Interest-2.38-1.30-0.07-0.28-0.15
Pre Tax Profit-30.94-28.73-21.18-16.93-13.25
Post Tax Profit-30.94-28.73-21.19-16.94-13.26
Profit for the Period-30.94-28.73-21.19-16.94-13.26
Equity Holders of Parent Company-30.94-28.73-21.19-16.94-13.26
Minority Interestsn/an/an/an/an/a
      
Continuing EPS     
Earnings per Share (Basic)-48.00 EUX-52.00 EUX-42.00 EUX-37.00 EUX-36.00 EUX
Earnings per Share (Diluted)-48.00 EUX-52.00 EUX-42.00 EUX-37.00 EUX-36.00 EUX
Earnings per Share (Adjusted)-48.00 EUX-52.00 EUX-42.00 EUX-37.00 EUX-36.00 EUX
Continuing and Discontinued EPS     
Earnings per Share (Basic)-48.00 EUX-52.00 EUX-42.00 EUX-37.00 EUX-36.00 EUX
Earnings per Share (Diluted)-48.00 EUX-52.00 EUX-42.00 EUX-37.00 EUX-36.00 EUX
Earnings per Share (Adjusted)-48.00 EUX-52.00 EUX-42.00 EUX-37.00 EUX-36.00 EUX
      
Dividend per Sharen/a EURn/a EURn/a EURn/a EURn/a EUR
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet31-12-202331-12-202231-12-202131-12-202031-12-2019
Non-Current Assets     
Intangible Assets1.091.150.900.560.53
Property, Plant and Equipment0.200.330.210.380.40
Investmentsn/an/an/an/an/a
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assets0.060.060.050.060.08
Total Non-Current Assets1.351.541.161.001.00
      
Current Assets     
Inventoriesn/an/an/an/an/a
Trade and Other Receivables1.992.745.173.262.14
Cash at Bank and in Hand6.886.996.854.117.06
Current Asset Investmentsn/an/an/an/an/a
Other Current Assetsn/an/an/an/an/a
Total Current Assets8.879.7312.027.379.20
      
Other Assetsn/an/an/an/an/a
Total Assets10.2211.2713.188.3710.21
      
Current Liabilities     
Borrowings3.642.000.610.300.30
Other Current Liabilities11.378.476.566.215.78
Total Current Liabilities15.0110.477.186.506.07
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings9.4711.272.932.932.52
Provisionsn/a0.16n/an/an/a
Other Non-Current Liabilities0.900.850.150.79n/a
Total Non-Current Liabilities10.3712.283.093.712.52
      
Net Assets-15.16-11.482.92-1.851.61
      
Capital and Reserves     
Share Capital2.692.692.692.692.69
Share Premium Accountn/an/an/an/a78.92
Other Reserves154.36129.55-116.2892.02n/a
Retained Earnings-172.21-143.71116.51-96.56-80.00
Shareholders Funds-15.16-11.482.92-1.851.61
      
Minority Interests / Other Equityn/an/an/an/an/a
Total Equity-15.16-11.482.92-1.851.61
      
 31-12-202331-12-202231-12-202131-12-202031-12-2019
Operating Marginn/a%n/a%n/a%n/a%n/a%
Return on Capital Employed910.39%-3,441.15%-379.16%-2,053.51%-335.66%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/an/an/an/an/a
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share-0.24 EUR-0.18 EUR0.03 EUR-0.04 EUR0.02 EUR